| Literature DB >> 26334743 |
Reuben Kiggundu1, Bozena M Morawski, Nathan C Bahr, Joshua Rhein, Abdu K Musubire, Darlisha A Williams, Mahsa Abassi, Henry W Nabeta, Kathy H Hullsiek, David B Meya, David R Boulware.
Abstract
The effect of tenofovir and amphotericin coadministration on kidney function is poorly characterized. We measured creatinine during induction therapy and at 4 weeks after diagnosis in Ugandans undergoing cryptococcal meningitis therapy and classified as not receiving antiretroviral therapy (ART), receiving nontenofovir ART or receiving tenofovir-based ART. Longitudinal creatinine changes and grade 2-4 creatinine adverse events were evaluated across groups. Creatinine concentrations were similar across ART groups. At 4 weeks after diagnosis, creatinine was 0.25 mg/dL higher than at diagnosis, but similar across groups. Adverse event incidence was also similar across ART groups. Tenofovir and amphotericin coadministration did not increase the risk of kidney dysfunction.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26334743 PMCID: PMC4713303 DOI: 10.1097/QAI.0000000000000812
Source DB: PubMed Journal: J Acquir Immune Defic Syndr ISSN: 1525-4135 Impact factor: 3.731